New Delhi | January 19, 2026
India’s long-awaited Free Trade Agreement (FTA) with the 27-nation European Union is nearing completion and is likely to be announced on January 27, coinciding with the 77th Republic Day celebrations and the 16th India–EU Summit.
Industry leaders say the agreement could double India’s exports to the EU within three years, supported by the gradual elimination of tariffs.
The FTA is expected to boost shipments of textiles, pharmaceuticals, chemicals, engineering goods, gems and jewelry, and other high-value sectors by offering improved and stable market access.
Exporters welcomed the upcoming deal, saying the FTA would provide a predictable trade framework, enabling long-term investments, supply chain integration, and stronger access to European value chains even amid global economic uncertainties.
EU Tariff Reduction to Improve Competitiveness
A. Sakthivel, Chairman of the Apparel Export Promotion Council (AEPC), called the FTA a game changer, noting that Indian exporters face high US tariffs and are seeking diversification into Europe.
At present, EU import duties on apparel and textiles range between 12–16%. Under the EU’s GSP/DCTS scheme, India enjoys some tariff preference, reducing the effective rate to 9.6%, but it still limits India’s competitiveness compared to FTA-backed rivals like Bangladesh and Vietnam.
The agreement focuses on areas where India already has a strong presence in Europe, including textiles, garments, pharmaceuticals, engineering goods, chemicals, and petroleum products.A Landmark Deal Expected to Shape Global Trade
The India–EU FTA is being described as the “mother of all trade agreements”, owing to its economic and geopolitical significance.
If concluded during the visit of European Council President António Costa and European Commission President Ursula von der Leyen, the pact would mark a major diplomatic breakthrough for both sides.
Analysts say it could reshape India’s global trade footprint and strengthen Europe’s partnerships in the Indo-Pacific.
Brazil, Nigeria Emerge as Key Pharma Export Destinations
Despite global economic volatility, Brazil and Nigeria have become major destinations for Indian pharmaceutical exports.
Commerce Ministry data shows:
Nigeria recorded a $179 million rise in pharma imports from India in the first eight months of FY26, contributing 14% to overall export growth.
Brazil saw an increase of nearly $100 million in the same period.
Officials say the trend highlights India’s role as a preferred supplier of affordable generics, owing to rising healthcare access and expanding public procurement in these countries.
Overall, India’s pharma exports rose 6.5% to $20.48 billion between April and November.
The United States remains India’s largest pharma export market, accounting for over 31% of shipments. France, the Netherlands, Canada, Germany, and South Africa also reported steady increases.
Notably, the Netherlands added $58 million in pharma imports from India, showing deeper integration of India into Europe’s pharmaceutical distribution network.
